211 related articles for article (PubMed ID: 30442990)
1. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine.
Tabe Y; Saitoh K; Yang H; Sekihara K; Yamatani K; Ruvolo V; Taka H; Kaga N; Kikkawa M; Arai H; Miida T; Andreeff M; Spagnuolo PA; Konopleva M
Sci Rep; 2018 Nov; 8(1):16837. PubMed ID: 30442990
[TBL] [Abstract][Full Text] [Related]
2. Bone Marrow Adipocytes Facilitate Fatty Acid Oxidation Activating AMPK and a Transcriptional Network Supporting Survival of Acute Monocytic Leukemia Cells.
Tabe Y; Yamamoto S; Saitoh K; Sekihara K; Monma N; Ikeo K; Mogushi K; Shikami M; Ruvolo V; Ishizawa J; Hail N; Kazuno S; Igarashi M; Matsushita H; Yamanaka Y; Arai H; Nagaoka I; Miida T; Hayashizaki Y; Konopleva M; Andreeff M
Cancer Res; 2017 Mar; 77(6):1453-1464. PubMed ID: 28108519
[TBL] [Abstract][Full Text] [Related]
3. Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML.
Tabe Y; Konopleva M; Andreeff M
Front Oncol; 2020; 10():155. PubMed ID: 32133293
[TBL] [Abstract][Full Text] [Related]
4. Consolidation Chemotherapy Prevents Relapse by Indirectly Regulating Bone Marrow Adipogenesis in Patients with Acute Myeloid Leukemia.
Liu H; Zhai Y; Zhao W; Wan Y; Lu W; Yang S; Yu Y; Wei Y; Li Z; Shi J
Cell Physiol Biochem; 2018; 45(6):2389-2400. PubMed ID: 29550830
[TBL] [Abstract][Full Text] [Related]
5. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.
Tabe Y; Shi YX; Zeng Z; Jin L; Shikami M; Hatanaka Y; Miida T; Hsu FJ; Andreeff M; Konopleva M
PLoS One; 2013; 8(6):e62785. PubMed ID: 23826077
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
[TBL] [Abstract][Full Text] [Related]
9. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment.
Shafat MS; Oellerich T; Mohr S; Robinson SD; Edwards DR; Marlein CR; Piddock RE; Fenech M; Zaitseva L; Abdul-Aziz A; Turner J; Watkins JA; Lawes M; Bowles KM; Rushworth SA
Blood; 2017 Mar; 129(10):1320-1332. PubMed ID: 28049638
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Garrido SM; Appelbaum FR; Willman CL; Banker DE
Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
[TBL] [Abstract][Full Text] [Related]
11. Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death.
Lee EA; Angka L; Rota SG; Hanlon T; Mitchell A; Hurren R; Wang XM; Gronda M; Boyaci E; Bojko B; Minden M; Sriskanthadevan S; Datti A; Wrana JL; Edginton A; Pawliszyn J; Joseph JW; Quadrilatero J; Schimmer AD; Spagnuolo PA
Cancer Res; 2015 Jun; 75(12):2478-88. PubMed ID: 26077472
[TBL] [Abstract][Full Text] [Related]
12. n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation.
Picou F; Debeissat C; Bourgeais J; Gallay N; Ferrié E; Foucault A; Ravalet N; Maciejewski A; Vallet N; Ducrocq E; Haddaoui L; Domenech J; Hérault O; Gyan E
Pharmacol Res; 2018 Oct; 136():45-55. PubMed ID: 30142422
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.
Zhai Y; Zhang J; Wang H; Lu W; Liu S; Yu Y; Weng W; Ding Z; Zhu Q; Shi J
J Exp Clin Cancer Res; 2016 Sep; 35(1):147. PubMed ID: 27643489
[TBL] [Abstract][Full Text] [Related]
14. [Energy metabolism of acute myeloid leukemia cells in the bone marrow microenvironment].
Tabe Y
Rinsho Ketsueki; 2022; 63(9):1046-1051. PubMed ID: 36198528
[TBL] [Abstract][Full Text] [Related]
15. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
16. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells.
Bertacchini J; Frasson C; Chiarini F; D'Avella D; Accordi B; Anselmi L; Barozzi P; Forghieri F; Luppi M; Martelli AM; Basso G; Najmaldin S; Khosravi A; Rahim F; Marmiroli S
Adv Biol Regul; 2018 May; 68():2-9. PubMed ID: 29576448
[TBL] [Abstract][Full Text] [Related]
18. Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
Hosseini M; Rezvani HR; Aroua N; Bosc C; Farge T; Saland E; Guyonnet-Dupérat V; Zaghdoudi S; Jarrou L; Larrue C; Sabatier M; Mouchel PL; Gotanègre M; Piechaczyk M; Bossis G; Récher C; Sarry JE
Cancer Res; 2019 Oct; 79(20):5191-5203. PubMed ID: 31358527
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
